Matches in Wikidata for { <http://www.wikidata.org/entity/Q91494056> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q91494056 description "article scientifique (publié 2018)" @default.
- Q91494056 description "articolo scientifico (pubblicato il 2018)" @default.
- Q91494056 description "artigo científico (publicado na 2018)" @default.
- Q91494056 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q91494056 description "artículo científico publicado en 2018" @default.
- Q91494056 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q91494056 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91494056 description "scientific article published on 01 January 2018" @default.
- Q91494056 description "wetenschappelijk artikel" @default.
- Q91494056 description "наукова стаття, опублікована 1 січня 2018" @default.
- Q91494056 description "научна статия" @default.
- Q91494056 name "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 name "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 name "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 type Item @default.
- Q91494056 label "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 label "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 label "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 prefLabel "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 prefLabel "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 prefLabel "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 P1433 Q91494056-73BCD58C-F5B8-41D3-B3A8-7199ED90130F @default.
- Q91494056 P1476 Q91494056-AD780D3A-77ED-4D0D-B2B5-187C4D81283F @default.
- Q91494056 P2093 Q91494056-1837A177-0177-4169-87AB-3A94F26BFB72 @default.
- Q91494056 P2093 Q91494056-A6E098BE-C19B-423D-9B5A-A1DEABA7E07C @default.
- Q91494056 P2093 Q91494056-B476800C-58B4-4FD2-8AB6-2D2A9E01B6B2 @default.
- Q91494056 P2093 Q91494056-BB6B7E53-D1B4-4386-8D17-29B0576B1DC8 @default.
- Q91494056 P2093 Q91494056-D0D91C37-07BE-4305-B61E-72FEA24E632B @default.
- Q91494056 P2093 Q91494056-F3C166DF-FB26-42D1-BB02-15E1E78FC2DF @default.
- Q91494056 P304 Q91494056-4E8CB6F3-CC39-48FE-B32D-86D26DD8D0E9 @default.
- Q91494056 P31 Q91494056-BB184797-A737-4441-8DB4-06CCE3BA33D8 @default.
- Q91494056 P356 Q91494056-518250BF-55C6-4CBC-9973-1DEBC8FE55CA @default.
- Q91494056 P433 Q91494056-9C3D4265-F51A-4E5D-8D86-F8C4BE443F2B @default.
- Q91494056 P478 Q91494056-AC01DA56-70BA-4F9B-84DA-7A32DC4B9D68 @default.
- Q91494056 P577 Q91494056-88EDB8CB-0F5A-4112-AE9F-DD569CC828C1 @default.
- Q91494056 P698 Q91494056-ED82C477-F1F0-4E8F-9905-7EA8FA2F1820 @default.
- Q91494056 P921 Q91494056-1FCA92AE-EA73-45A4-842D-B65EF712CB2F @default.
- Q91494056 P356 DDT.2018.01043 @default.
- Q91494056 P698 30224597 @default.
- Q91494056 P1433 Q15752935 @default.
- Q91494056 P1476 "Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream" @default.
- Q91494056 P2093 "Fumiyoshi Ishii" @default.
- Q91494056 P2093 "Ken-Ichi Shimokawa" @default.
- Q91494056 P2093 "Miyuki Kumazawa" @default.
- Q91494056 P2093 "Motoari Takata" @default.
- Q91494056 P2093 "Yuko Wada" @default.
- Q91494056 P2093 "Yurika Iwasawa" @default.
- Q91494056 P304 "248-253" @default.
- Q91494056 P31 Q13442814 @default.
- Q91494056 P356 "10.5582/DDT.2018.01043" @default.
- Q91494056 P433 "4" @default.
- Q91494056 P478 "12" @default.
- Q91494056 P577 "2018-01-01T00:00:00Z" @default.
- Q91494056 P698 "30224597" @default.
- Q91494056 P921 Q415259 @default.